Initial testing choice between coronary CTA and stress testing for suspected CAD showed no difference in all-cause or cardiovascular mortality among patients with stable symptoms. ja.ma/4g2sbdqView quoted post on X
Daniel Mark
Verified account This account is verified. Learn more@DanMarkMD
Physician, cardiologist, cardiac intensivist, Duke University faculty, clinical researcher, EiC American Heart Journal
2.1K Following 2.9K Followers 5.6K Posts
Latest posts 5
Low-quality papers are surging by exploiting public data sets and AI | Science | AAAS science.org/content/articl…
Viewpoint by Derek Chew, @EmilyZeitler, & @DanMarkMD: While extended ECG monitoring technologies are increasingly detecting subclinical atrial fibrillation (SCAF), the benefits of anticoagulation therapy for this population remain uncertain. ja.ma/41seRczView quoted post on X
“Solely applying a P value threshold or 95% CI to determine if a treatment works or not is an [often misleading] oversimplification.”
How do we make sense of two “negative” trials in @NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence? @emil_hs and @FralickMike share some insights in this editorial: eviden.cc/3OYutgJView quoted post on X
Viewpoint by Derek Chew, @EmilyZeitler, & @DanMarkMD: While extended ECG monitoring technologies are increasingly detecting subclinical atrial fibrillation (SCAF), the benefits of anticoagulation therapy for this population remain uncertain.View quoted post on X
ja.ma/3Z7Uwbn